NBTY Global Health Sciences $40 Mil. Acquisition Approval Pending
This article was originally published in The Tan Sheet
Executive Summary
NBTY intends to keep intact bankrupt Global Health Sciences' contract manufacturing business instead of using the acquired capacity for its own purposes, the supplement manufacturer told analysts during a conference call April 26.